JPH01500745A - 注射可能なビタミン組成物 - Google Patents

注射可能なビタミン組成物

Info

Publication number
JPH01500745A
JPH01500745A JP59501884A JP50188484A JPH01500745A JP H01500745 A JPH01500745 A JP H01500745A JP 59501884 A JP59501884 A JP 59501884A JP 50188484 A JP50188484 A JP 50188484A JP H01500745 A JPH01500745 A JP H01500745A
Authority
JP
Japan
Prior art keywords
vitamin
composition according
vitamin composition
item
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP59501884A
Other languages
English (en)
Japanese (ja)
Inventor
スペーツケ，アンドレ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of JPH01500745A publication Critical patent/JPH01500745A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
JP59501884A 1983-05-03 1984-05-02 注射可能なビタミン組成物 Pending JPH01500745A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
LU84787 1983-05-03
LU84787 1983-05-03

Publications (1)

Publication Number Publication Date
JPH01500745A true JPH01500745A (ja) 1989-03-16

Family

ID=19730091

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59501884A Pending JPH01500745A (ja) 1983-05-03 1984-05-02 注射可能なビタミン組成物

Country Status (9)

Country Link
EP (1) EP0155941A1 (da)
JP (1) JPH01500745A (da)
CA (1) CA1226522A (da)
DK (1) DK3685A (da)
IE (1) IE58361B1 (da)
IT (1) IT1180165B (da)
PT (1) PT78541B (da)
WO (1) WO1984004243A2 (da)
ZA (1) ZA843279B (da)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998006410A1 (en) * 1996-08-12 1998-02-19 Taisho Pharmaceutical Co., Ltd. Zinc-containing composition

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4600586A (en) * 1983-08-08 1986-07-15 Green Milton L Livestock feed lot adaptation composition and method
FR2599967B1 (fr) * 1986-06-16 1989-03-31 Bfb Etudes Rech Experimentale Utilisation de sel de zinc et de la vitamine b6 pour enrayer les processus alopeciques et/ou seborrheiques.
NZ222664A (en) * 1986-11-29 1990-06-26 Vesta Med Pty Ltd Pharmaceutical compositions containing pyridoxal as a source of vitamin b6
FR2625414B1 (fr) * 1987-12-31 1990-06-01 Unicor Union Cooperatives Agri Melange d'ingredients nutritionnels pour l'alimentation des ruminants
NZ272317A (en) * 1995-06-09 1997-07-27 Bomac Lab Ltd Veterinary formulation; comprises calcium borogluconate, vitamin b12 or a derivative thereof and a carrier; treatment of milk fever in animals
DE19731432C2 (de) * 1997-07-22 1999-07-15 Phoenix Lab Pharmazeutische Pr Verwendung von Cholincitrat
BR112022000558A2 (pt) * 2019-07-12 2022-03-15 Chemvet Australia Pty Ltd Suplemento nutricional injetável

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5176436A (ja) * 1974-12-24 1976-07-02 Kumiai Chemical Industry Co Dobutsuyohinketsuyobo chiryozai
JPS5283905A (en) * 1976-01-01 1977-07-13 Nippon Zoki Pharmaceutical Co Production of dextrin hydroxycarboxylic acid and ferric multinuclear complex
JPS5775914A (en) * 1980-08-20 1982-05-12 Giyunsaa Uoorikuzeku Eruin Manufacture of cuprous complex solution
JPS5782318A (en) * 1980-09-19 1982-05-22 Garufuinkeru Doron Novel drug composition containing zinc salt

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5176436A (ja) * 1974-12-24 1976-07-02 Kumiai Chemical Industry Co Dobutsuyohinketsuyobo chiryozai
JPS5283905A (en) * 1976-01-01 1977-07-13 Nippon Zoki Pharmaceutical Co Production of dextrin hydroxycarboxylic acid and ferric multinuclear complex
JPS5775914A (en) * 1980-08-20 1982-05-12 Giyunsaa Uoorikuzeku Eruin Manufacture of cuprous complex solution
JPS5782318A (en) * 1980-09-19 1982-05-22 Garufuinkeru Doron Novel drug composition containing zinc salt

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998006410A1 (en) * 1996-08-12 1998-02-19 Taisho Pharmaceutical Co., Ltd. Zinc-containing composition

Also Published As

Publication number Publication date
DK3685D0 (da) 1985-01-03
DK3685A (da) 1985-01-03
PT78541A (fr) 1984-06-01
ZA843279B (en) 1985-03-27
WO1984004243A3 (fr) 1985-03-14
CA1226522A (fr) 1987-09-08
PT78541B (fr) 1986-07-14
WO1984004243A2 (fr) 1984-11-08
IE58361B1 (en) 1993-09-08
IT1180165B (it) 1987-09-23
IT8420758A1 (it) 1985-11-02
IE841087L (en) 1984-11-03
IT8420758A0 (it) 1984-05-02
EP0155941A1 (fr) 1985-10-02

Similar Documents

Publication Publication Date Title
US9616133B2 (en) Orally administrable gallium compositions and methods of use
US4415576A (en) Method for preventing body fat deposition in mammals
JPS58126767A (ja) 肝臓病患者用栄養組成物
DE69432644T2 (de) Kombination eines Angiotensin-II antagonistisch wirkendes Benzimidazols mit ein Diuretikum
DE3709621A1 (de) Therapeutisches mittel
PT1372650E (pt) Associações compreendendo um agente antidiarreico e uma epotilona ou um derivado de epotilona
KR910009272A (ko) 메일라아드 반응의 억제를 위한 제약조성물 및 방법
JP2004531549A5 (da)
EP1318804B1 (en) Iron compositions
JPH01500745A (ja) 注射可能なビタミン組成物
US2877253A (en) Therapeutic iron complex
DE60033044T2 (de) Zusammensetzung von morphin methansulphonat und chitosan zur nasalen verabreicherung
DE69029732T2 (de) Bivalente metallsalze von indomethacin
CA2311024C (en) Pharmaceutical composition for oral administration of chelating agents
Lipsky et al. Treatment of Wilson's disease: In d-penicillamine we trust—what about zinc?
US5434142A (en) Method of treatment for muscular dystrophy
JPS615017A (ja) 抗潰瘍組成物
DE60113808T2 (de) Therapeutikum oder Prophylaktikum für Lebererkrankungen, enthaltend ein Diaminotrifluorethylpyridin-Derivat
Salgo et al. Fetal resorption induced by disulfiram in rats
KR930011994B1 (ko) 파라세타몰의 생체이용율을 높이는 방법 및 이 생체이용율이 높아진 파라세타몰을 함유한 제제
DE2759108A1 (de) Verwendung von alpha -mercapto-beta- aryl-acrylsaeuren bei der steigerung des zinkgehaltes im serum und im gewebe
Wadhwani Mitigation of Fluorosis (Experimental). Part I
DE1793769C2 (de) Verfahren zur Herstellung von Bis-(thiosemicarbazonen). Ausscheidung aus: 151205
Johannesson et al. Thionapthene-2-carboxylic acid: a new antihypercalcemic agent
Bereda Anaemia and antianaemic medications